316. Carnitine cycle disorder Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 4 Drugs : 10 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 11

Drugs and their primary sponsors and trial info
Bezafibrate   
   Rigshospitalet, Denmark
      2009   Phase 2   NCT00983788   Denmark;
Bezafibrate (drug)   
   Assistance Publique - Hôpitaux de Paris
      2006   Phase 3   NCT00336167   France;
Break in L-carnitine treatment   
   Karen Lindhardt Madsen
      2013   -   NCT02226419   -
Glycerol/Saline   
   Oregon Health and Science University
      2016   -   NCT02517307   United States;
Hyperinsulinemic euglycemic clamp   
   Oregon Health and Science University
      2016   -   NCT02517307   United States;
Intralipid/Heparin   
   Oregon Health and Science University
      2016   -   NCT02517307   United States;